Who Qualifies for Clinical Trial Support in Michigan
GrantID: 14414
Grant Funding Amount Low: $150,000
Deadline: Ongoing
Grant Amount High: $450,000
Summary
Explore related grant categories to find additional funding opportunities aligned with this program:
Grant Overview
Target Outcomes for Michigan's Pancreatic Cancer Clinical Trials
Michigan is poised to make significant strides in addressing the disparities in pancreatic cancer clinical trial participation, particularly among underrepresented minority groups. The Michigan Department of Health and Human Services (MDHHS) has been actively working to improve health outcomes for its diverse population. The target outcomes for this grant in Michigan focus on increasing the recruitment and retention of patients from underrepresented minority groups in pancreatic cancer clinical trials through specific, achievable, and measurable goals.
Measurable Goals for Clinical Trial Recruitment and Retention
Programs in Michigan will be supported if they can demonstrate clear objectives and a robust plan for achieving the following outcomes:
-
Increase diverse patient enrollment: Programs should aim to enroll a higher percentage of underrepresented minority patients in pancreatic cancer clinical trials compared to current baseline data. Michigan's diverse population, with significant African American and Hispanic communities, particularly in Detroit, presents both a challenge and an opportunity for targeted outreach and engagement.
-
Improve patient retention rates: Retention strategies are crucial for the success of clinical trials. Programs should focus on implementing effective patient education, support mechanisms, and follow-up procedures to ensure that participants from underrepresented minority groups remain engaged throughout the trial process.
-
Enhance community outreach and education: Building trust within underrepresented communities is essential for increasing participation in clinical trials. Programs should develop and implement culturally sensitive outreach and education initiatives that address the specific needs and concerns of these communities in Michigan.
-
Strengthen clinical trial infrastructure: To support the increased recruitment and retention of diverse patients, programs may need to enhance their clinical trial infrastructure. This could involve training for clinical recruitment staff, improving patient navigation services, and ensuring that trial protocols are inclusive and accessible.
The Upper Peninsula's rural landscape and the Detroit metropolitan area present unique challenges and opportunities for outreach and engagement. For example, leveraging partnerships with local health organizations and utilizing digital health technologies could help reach underrepresented populations in both rural and urban settings.
Evaluating Success and Driving Progress
Success will be evaluated based on the achievement of the proposed outcomes, including the number of underrepresented minority patients enrolled and retained in pancreatic cancer clinical trials, and the effectiveness of community outreach and education efforts. The Michigan Cancer Consortium, a statewide organization that works to reduce the cancer burden, will be a key partner in tracking progress and identifying best practices.
Michigan applicants should be aware of the state's existing initiatives and resources that can support their proposals, such as the Michigan Clinical Trials Office and the state's participation in the National Cancer Institute's (NCI) Community Oncology Research Program (NCORP). By aligning their proposals with these existing efforts, applicants can leverage additional resources and expertise to drive progress towards the target outcomes.
Q: What are the key factors that reviewers will consider when evaluating proposals for this grant in Michigan? A: Reviewers will consider the proposed outcomes, the likelihood of achieving them, and the overall impact on increasing the recruitment and retention of underrepresented minority patients in pancreatic cancer clinical trials.
Q: How can applicants in Michigan access resources and support for their proposals? A: Applicants can reach out to the Michigan Department of Health and Human Services and the Michigan Cancer Consortium for guidance and potential partnerships.
Q: What is the anticipated timeline for grant award announcements in Michigan? A: While specific timelines may vary, applicants can typically expect a thorough review process that takes several months, with award announcements made shortly thereafter.
Eligible Regions
Interests
Eligible Requirements
Related Searches
Related Grants
Grant for Emerging Researchers in Science and Technology
This grant opportunity is designed to support individuals engaged in early-stage research across var...
TGP Grant ID:
70558
Grants to Support Educational Initiatives Around the Country
This grant program is dedicated to supporting children's educational and developmental needs, wi...
TGP Grant ID:
72891
Emergency Water Assistance Grant Program
Helps and provide assistance to New York's eligible communities prepare, or recover from, a...
TGP Grant ID:
21486
Grant for Emerging Researchers in Science and Technology
Deadline :
Ongoing
Funding Amount:
Open
This grant opportunity is designed to support individuals engaged in early-stage research across various scientific and technical fields within the Un...
TGP Grant ID:
70558
Grants to Support Educational Initiatives Around the Country
Deadline :
Ongoing
Funding Amount:
$0
This grant program is dedicated to supporting children's educational and developmental needs, with a focus on fostering their growth into producti...
TGP Grant ID:
72891
Emergency Water Assistance Grant Program
Deadline :
2099-12-31
Funding Amount:
$0
Helps and provide assistance to New York's eligible communities prepare, or recover from, an emergency that threatens the availability of saf...
TGP Grant ID:
21486